RECURRENT LUNG NON-SMALL CELL CARCINOMA
Clinical trials for RECURRENT LUNG NON-SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT LUNG NON-SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT LUNG NON-SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to shrink Hard-to-Treat lung tumors
Disease control Not yet recruitingThis study tests two drugs, alone or together, for people with advanced non-small cell lung cancer that has specific gene changes (like EGFR or ALK) and has come back after prior treatment. The drugs are sacituzumab govitecan, which delivers a toxin directly to cancer cells, and …
Matched conditions: RECURRENT LUNG NON-SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated May 26, 2026 04:23 UTC
-
New hope for advanced lung cancer patients: drug combo aims to reawaken immune system
Disease control Not yet recruitingThis study tests a new two-drug combination (SX-682 and atezolizumab) for people with advanced non-small cell lung cancer whose cancer continued to grow after chemotherapy and immunotherapy. The goal is to see if the combination can shrink tumors or slow the disease. About 32 adu…
Matched conditions: RECURRENT LUNG NON-SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated May 26, 2026 03:58 UTC